Milanlioglu, Aysel2025-05-102025-05-1020121018-86811309-574910.5350/DAJPN20122504142-s2.0-84875241380https://doi.org/10.5350/DAJPN2012250414https://hdl.handle.net/20.500.14720/1404Restless legs syndrome is a movement disorder characterized by complaints of a strong urge to move the legs predominantly during the periods of rest or inactivity. It is observed as a side effect related to the administration of antidepressants in 9% of patients. A case reporting restless legs syndrome symptoms associated with venlafaxine 75 mg/day is decribed. The patient was a 44-year-old woman affected by chronic migraine headaches with depressive symptoms. Her symptoms had began during a course of venlafaxine and resolved with its discontinuation. Based on this report, venlafaxine should be added to the list of agents that can induce restless legs syndrome.eninfo:eu-repo/semantics/openAccessAntidepressantsRestless Legs SyndromeVenlafaxineSerotonin-Norepinephrine Reuptake InhibitorsArticle254N/AQ3388389WOS:000421427300015